Proton Therapy

Proton therapy is a type of external beam radiation that uses protons, which are positively charged particles, to treat cancer. In conventional radiotherapy, X-ray beams pass right through the body, depositing radiation along their whole path, both before and beyond the tumour. A proton beam behaves differently: it can be tuned to slow down and release the bulk of its energy precisely at the depth of the tumour, a behaviour known as the Bragg peak, and then it stops, with almost no dose delivered beyond that point. The result is that the tumour receives a high, effective dose while the healthy tissues in front of it receive less and those behind it are largely spared. Modern systems steer a fine beam back and forth to paint the dose across the tumour layer by layer, shaping it closely to even an irregular target. This sparing of surrounding tissue is the reason proton therapy is chosen for certain tumours rather than as a replacement for all radiotherapy.

Proton therapy is recommended when sparing the tissue around a tumour is particularly important, so the choice depends on the type and the location of the cancer rather than on the cancer alone. It is widely used for children, because reducing the radiation reaching developing organs lowers the risk of long-term effects on growth and of late complications. In adults it is often considered for tumours of the brain and the base of the skull, including chordomas and chondrosarcomas, for many head and neck cancers, for tumours close to the spinal cord, for certain tumours of the eye, and for selected prostate, lung, liver and other tumours where nearby structures must be protected. It is also valuable when a tumour sits very close to a critical organ, or when a previous course of radiation limits how much further dose the surrounding tissue can safely receive. The decision is made by a radiation oncology team after reviewing the diagnosis, the imaging and the goals of treatment, sometimes in comparison with standard radiotherapy.

Proton therapy is carefully planned before the first dose is given. The process begins with detailed imaging, usually a planning CT scan and often MRI or PET images, taken in the exact position the patient will hold during treatment; a custom mould or mask is made to keep the body or head perfectly still and reproducible each day. Using these images, the team maps the tumour and the organs to avoid and designs a plan that shapes the proton dose to the target, a step that takes several days of physics and quality checks. Treatment itself is then delivered as a series of short daily sessions, typically on weekdays over a number of weeks, with rest at weekends; the number of sessions depends on the tumour. At each session the patient lies still on a couch while the machine, often a rotating gantry, directs the beam from the planned angles. The delivery is silent and completely painless, lasts only a few minutes, and nothing is felt during it. Adults need no anaesthesia, while very young children may receive light sedation so they can stay still, and the team checks the position with imaging before each treatment.

A suitable candidate is a patient whose tumour type and location stand to benefit from the way proton therapy spares healthy tissue, and who is well enough to attend a planned course of daily sessions. Preparation centres on accurate planning rather than on surgical fitness: it includes the planning scans in the treatment position, the making of the immobilisation mould or mask, and a review of previous treatment and overall health. For some tumours, small markers may be placed to guide daily positioning, or dental and nutritional preparation may be advised before head and neck treatment. Because each plan is built individually, there is a gap of several days between planning and the first session. Proton therapy is not the right answer for every cancer; where standard radiotherapy gives an equally good result, it may be preferred, and widespread disease is usually treated in other ways. For international patients, the diagnosis, pathology and scans can be reviewed remotely first, so suitability is largely confirmed before travel and the planning visit sets the schedule.

Recovery from proton therapy is generally gentler than many people expect, because the treatment is non-invasive and the sparing of healthy tissue tends to reduce side effects. Most are mild and build up gradually over the course, then settle in the weeks after it ends; they depend on the area treated and can include tiredness, some skin redness over the treated site, or local effects such as a sore mouth when the head and neck are treated. Daily life can usually continue during treatment, with rest as needed. For a course abroad, it is important to plan a continuous stay that covers the full schedule, since the sessions run on weekdays over several weeks and should not be interrupted; comfortable nearby accommodation makes the daily visits easier. Flying home is normally arranged once the course is finished and a first review confirms that recovery is on track. After that, follow-up continues with scans and reviews that can largely be carried out closer to home, with the treating centre reachable for advice, and international patient teams commonly provide interpreters and coordinators so language is never a barrier.

Proton therapy is a safe, well-established treatment delivered in highly specialised centres, and its main purpose is to achieve effective tumour control while reducing the dose to healthy tissue and so lowering the risk of side effects compared with conventional radiation. Like all radiotherapy it can still cause effects, which are mostly mild and confined to the area treated: temporary tiredness, skin changes over the site, and local symptoms that depend on the region, such as a sore throat, swallowing discomfort or hair loss limited to the treated area. These usually improve in the weeks after the course ends. Less commonly, effects can appear or persist later, which is why long-term follow-up is part of the plan. The particular benefit for children is a lower dose to developing tissue, which is thought to reduce certain late risks. Being treated by an experienced team, completing the full planned course and keeping to follow-up are the keys to a safe experience and to giving the treatment the best chance of a lasting result.